The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Prevention of preeclampsia with aspirin
Abstract
Preeclampsia is defined as hypertension arising after 20 weeks of gestational age with proteinuria or other signs of end-organ damage and is a significant cause of maternal and perinatal morbidity and mortality, particularly when of early onset. Although a significant amount of research has been dedicated in identifying preventive measures for preeclampsia, the incidence of the condition has been relatively unchanged in the last decades. This could be attributed to the fact that the underlying pathophysiology of preeclampsia is not entirely understood. There is increasing evidence suggesting that suboptimal trophoblastic invasion leads to an imbalance of angiogenic and anti-angiogenic proteins, ultimately causing widespread inflammation and endothelial damage, increased platelet aggregation and thrombotic events with placental infarcts. Aspirin at doses below 300 mg selectively and irreversibly inactivates the cyclooxygenase-1 enzyme, suppressing the production of prostaglandins and thromboxane and inhibiting inflammation and platelet aggregation. Such an effect has led to the hypothesis that aspirin could be useful for preventing preeclampsia. The first possible link between the use of aspirin and the prevention of preeclampsia was suggested by a case report published in 1978, followed by the first randomized controlled trial published in 1985. Since then, numerous randomized trials have been published, demonstrating the safety of the use of aspirin in pregnancy and the inconsistent effects of aspirin on the rates of preeclampsia. These inconsistencies, however, can be largely explained by a high degree of heterogeneity regarding the selection of trial participants, baseline risk of the included women, dose of aspirin, gestational age of prophylaxis initiation and preeclampsia definition. An individual patient data meta-analysis has demonstrated a modest 10% reduction in preeclampsia rates with the use of aspirin, but later meta-analyses of aggregate data have shown a dose-response effect of aspirin on preeclampsia rates, which is maximized when the medication is initiated before 16 weeks of gestational age. Recently, the Aspirin for Evidence-based Preeclampsia Prevention (ASPRE) trial has demonstrated that aspirin at a daily dose of 150 mg, initiated before 16 weeks of gestational age, and given at night to a high-risk population, identified by a combined first trimester screening test, reduces the incidence of preterm preeclampsia by 62%. A secondary analysis of the ASPRE trial data also demonstrated a reduction in the length of stay in the neonatal intensive care unit by 68%, compared with placebo, mainly due to a reduction in births before 32 weeks of gestational age with preeclampsia. The beneficial effect of aspirin has been shown to be similar in subgroups according to different maternal characteristics, except for the presence of chronic hypertension, where no beneficial effect is evident. In addition, the effect size of aspirin has been shown to be more pronounced in women with good compliance to treatment. In general, randomized trials are underpowered to investigate the treatment effect of aspirin on the rates of other placental-associated adverse outcomes such as fetal growth restriction and stillbirth. This article summarizes the evidence around aspirin for the prevention of preeclampsia and its complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs
VANE, J. R. (1971) · Nature New Biology · doi:10.1038/newbio231232a0 · Cited by 8,605
Epidemiology and causes of preterm birth
Goldenberg, R. L., Culhane, J. F., Iams, J. D., & Romero, R. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60074-4 · Cited by 7,801 · cited 1×
“A subset of pregnant women with spontaneous preterm birth has placental lesions associated with uteroplacental ischemia and abnormal uterine artery Doppler, findings that are frequently observed in women with preeclampsia, and therefore, it has been suggested that placental insufficiency may play a role in the spontan…”
BackgroundHansson, L., Zanchetti, A., Carruthers, S. G., Dahlöf, B., Elmfeldt, D., Julius, S., Ménard, J., Rahn, K. H., Wedel, H., & Westerling, S. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04311-6 · Cited by 5,728
The Global Impact of Pre-eclampsia and Eclampsia
Duley, L. (2009) · Seminars in Perinatology · doi:10.1053/j.semperi.2009.02.010 · Cited by 2,866
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia
Rolnik, D. L., Wright, D., Poon, L. C., O’Gorman, N., Syngelaki, A., de Paco Matallana, C., Akolekar, R., Cicero, S., Janga, D., Singh, M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1704559 · Cited by 2,287
Self-citationMosca, L., Benjamin, E. J., Berra, K., Bezanson, J. L., Dolor, R. J., Lloyd-Jones, D. M., Newby, L. K., Piña, I. L., Roger, V. L., Shaw, L. J., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31820faaf8 · Cited by 2,143
Long-Term Medical and Social Consequences of Preterm Birth
Moster, D., Lie, R. T., & Markestad, T. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706475 · Cited by 1,402
Pre-eclampsia: pathophysiology and clinical implications
Burton, G. J., Redman, C. W., Roberts, J. M., & Moffett, A. (2019) · BMJ · doi:10.1136/bmj.l2381 · Cited by 1,250
Poon, L. C., Shennan, A., Hyett, J. A., Kapur, A., Hadar, E., Divakar, H., McAuliffe, F., da Silva Costa, F., von Dadelszen, P., McIntyre, H. D., et al. (2019) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12802 · Cited by 1,238
Self-citationThe mechanism of action of aspirin
Vane, J. R., & Botting, R. M. (2003) · Thrombosis Research · doi:10.1016/s0049-3848(03)00379-7 · Cited by 1,225
Preeclampsia and Future Cardiovascular Health: A Systematic Review and Meta-Analysis
Wu, P., Haththotuwa, R., Kwok, C. S., Babu, A., Kotronias, R. A., Rushton, C., Zaman, A., Fryer, A. A., Kadam, U., Chew-Graham, C. A., et al. (2017) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.116.003497 · Cited by 1,147
Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly
McNeil, J. J., Wolfe, R., Woods, R. L., Tonkin, A. M., Donnan, G. A., Nelson, M. R., Reid, C. M., Lockery, J. E., Kirpach, B., Storey, E., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1805819 · Cited by 1,139 · cited 1×
“Analogously, universal aspirin for primary prevention of cardiovascular events in healthy older adults resulted in a significantly higher risk of major hemorrhage but did not significantly reduce the risk of cardiovascular disease.(85)”
BackgroundBujold, E., Roberge, S., Lacasse, Y., Bureau, M., Audibert, F., Marcoux, S., Forest, J.-C., & Giguère, Y. (2010) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3181e9322a · Cited by 1,092
Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data
Askie, L. M., Duley, L., Henderson-Smart, D. J., & Stewart, L. A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60712-0 · Cited by 1,020
Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis
Ananth, C. V., Keyes, K. M., & Wapner, R. J. (2013) · BMJ · doi:10.1136/bmj.f6564 · Cited by 940
Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women—2011 Update
Mosca, L., Benjamin, E. J., Berra, K., Bezanson, J. L., Dolor, R. J., Lloyd-Jones, D. M., Newby, L. K., Piña, I. L., Roger, V. L., Shaw, L. J., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.02.005 · Cited by 782
ACOG Committee Opinion No. 743: Low-Dose Aspirin Use During Pregnancy
(2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002708 · Cited by 711
Roberge, S., Nicolaides, K., Demers, S., Hyett, J., Chaillet, N., & Bujold, E. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.09.076 · Cited by 679
Self-citationLykke, J. A., Langhoff-Roos, J., Sibai, B. M., Funai, E. F., Triche, E. W., & Paidas, M. J. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.130765 · Cited by 672
O’Gorman, N., Wright, D., Syngelaki, A., Akolekar, R., Wright, A., Poon, L. C., & Nicolaides, K. H. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.08.034 · Cited by 629
Self-citationAspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis
Roberge, S., Bujold, E., & Nicolaides, K. H. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.11.561 · Cited by 628
Self-citationCompeting Risks Model in Early Screening for Preeclampsia by Biophysical and Biochemical Markers
Akolekar, R., Syngelaki, A., Poon, L., Wright, D., & Nicolaides, K. H. (2013) · Fetal Diagnosis and Therapy · doi:10.1159/000341264 · Cited by 601
Self-citationPrevention of Preeclampsia with Low-Dose Aspirin in Healthy, Nulliparous Pregnant Women
Sibai, B. M., Caritis, S. N., Thom, E., Klebanoff, M., McNellis, D., Rocco, L., Paul, R. H., Romero, R., Witter, F., Rosen, M., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199310213291701 · Cited by 558
Hypertensive disorders in twin versus singleton gestations
Sibai, B. M., Hauth, J., Caritis, S., Lindheimer, M. D., MacPherson, C., Klebanoff, M., VanDorsten, J. P., Landon, M., Miodovnik, M., Paul, R., et al. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(00)70350-4 · Cited by 539
LeFevre, M. L., & on behalf of the U.S. Preventive Services Task Force* (2014) · Annals of Internal Medicine · doi:10.7326/m14-1884 · Cited by 487
PREVENTION OF PRE-ECLAMPSIA BY EARLY ANTIPLATELET THERAPY
Beaufils, M., Donsimoni, R., Uzan, S., & Colau, J. C. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92207-x · Cited by 474
ASPRE trial: performance of screening for preterm pre‐eclampsia
Rolnik, D. L., Wright, D., Poon, L. C. Y., Syngelaki, A., O'Gorman, N., de Paco Matallana, C., Akolekar, R., Cicero, S., Janga, D., Singh, M., et al. (2017) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.18816 · Cited by 464
Self-citationPrevention of perinatal death and adverse perinatal outcome using low‐dose aspirin: a meta‐analysis
Roberge, S., Nicolaides, K. H., Demers, S., Villa, P., & Bujold, E. (2013) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.12421 · Cited by 391
Self-citationTan, M. Y., Wright, D., Syngelaki, A., Akolekar, R., Cicero, S., Janga, D., Singh, M., Greco, E., Wright, A., Maclagan, K., et al. (2018) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.19039 · Cited by 385
Self-citationRoberge, S., Villa, P., Nicolaides, K., Giguère, Y., Vainio, M., Bakthi, A., Ebrashy, A., & Bujold, E. (2012) · Fetal Diagnosis and Therapy · doi:10.1159/000336662 · Cited by 381
Self-citationBrown, H. L., Warner, J. J., Gianos, E., Gulati, M., Hill, A. J., Hollier, L. M., Rosen, S. E., Rosser, M. L., & Wenger, N. K. (2018) · Circulation · doi:10.1161/cir.0000000000000582 · Cited by 378
Hoffman, M. K., Goudar, S. S., Kodkany, B. S., Metgud, M., Somannavar, M., Okitawutshu, J., Lokangaka, A., Tshefu, A., Bose, C. L., Mwapule, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(19)32973-3 · Cited by 360
The first 3500 years of aspirin history from its roots – A concise summary
Montinari, M. R., Minelli, S., & De Caterina, R. (2019) · Vascular Pharmacology · doi:10.1016/j.vph.2018.10.008 · Cited by 315
Diagnosis and management of hypertension in pregnancy: summary of updated NICE guidance
Webster, K., Fishburn, S., Maresh, M., Findlay, S. C., & Chappell, L. C. (2019) · BMJ · doi:10.1136/bmj.l5119 · Cited by 302
SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014
Lowe, S. A., Bowyer, L., Lust, K., McMahon, L. P., Morton, M., North, R. A., Paech, M., & Said, J. M. (2015) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.12399 · Cited by 299 · cited 1×
“These later meta-analyses have been criticized because of the use of aggregate data, which may overestimate the effect size of aspirin as compared with individual patient data meta-analyses, the inclusion of a small number of heterogeneous studies, and the fact that the subgroup that received aspirin before 16 weeks o…”
ResultShort-term costs of preeclampsia to the United States health care system
Stevens, W., Shih, T., Incerti, D., Ton, T. G. N., Lee, H. C., Peneva, D., Macones, G. A., Sibai, B. M., & Jena, A. B. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.04.032 · Cited by 286
O'Gorman, N., Wright, D., Poon, L. C., Rolnik, D. L., Syngelaki, A., Wright, A., Akolekar, R., Cicero, S., Janga, D., Jani, J., et al. (2017) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.17399 · Cited by 259
Self-citationRole of the Placenta in Preterm Birth: A Review
Morgan, T. (2016) · American Journal of Perinatology · doi:10.1055/s-0035-1570379 · Cited by 237
Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?
Bdolah, Y., Lam, C., Rajakumar, A., Shivalingappa, V., Mutter, W., Sachs, B. P., Lim, K. H., Bdolah-Abram, T., Epstein, F. H., & Karumanchi, S. A. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.10.783 · Cited by 235
A Competing Risks Model in Early Screening for Preeclampsia
Wright, D., Akolekar, R., Syngelaki, A., Poon, L. C. Y., & Nicolaides, K. H. (2012) · Fetal Diagnosis and Therapy · doi:10.1159/000338470 · Cited by 235
Self-citationCardiovascular System in Preeclampsia and Beyond
Thilaganathan, B., & Kalafat, E. (2019) · Hypertension · doi:10.1161/hypertensionaha.118.11191 · Cited by 234
Adult cardiovascular risk factors in premature babies
Szathmári, M., Väsärhelyi, B., Reusz, G., & Tulassay, T. (2000) · The Lancet · doi:10.1016/s0140-6736(05)73920-9 · Cited by 230
Adult cardiovascular risk factors in premature babies
Irving, R. J., Belton, N. R., Elton, R. A., & Walker, B. R. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02384-9 · Cited by 230
ASPIRIN AND CONGENITAL MALFORMATIONS
Slone, D., Heinonen, O., Kaufman, D., Siskind, V., Monson, R., & Shapiro, S. (1976) · The Lancet · doi:10.1016/s0140-6736(76)93025-7 · Cited by 223
The discovery of aspirin's antithrombotic effects.
Miner, J. J., & Hoffhines, A. J. (2007) · PubMed · Cited by 212
Chronotherapy With Low-Dose Aspirin for Prevention of Complications in Pregnancy
Ayala, D. E., Ucieda, R., & Hermida, R. C. (2013) · Chronobiology International · doi:10.3109/07420528.2012.717455 · Cited by 203
Poon, L. C., Wright, D., Rolnik, D. L., Syngelaki, A., Delgado, J. L., Tsokaki, T., Leipold, G., Akolekar, R., Shearing, S., De Stefani, L., et al. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.07.038 · Cited by 198
Self-citationRotchell, Y. E., Cruickshank, J. K., Phillips Gay, M., Griffiths, J., Stewart, A., Farrell, B., Ayers, S., Hennis, A., Grant, A., Duley, L., et al. (1998) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1998.tb10088.x · Cited by 197
Wright, D., Poon, L. C., Rolnik, D. L., Syngelaki, A., Delgado, J. L., Vojtassakova, D., de Alvarado, M., Kapeti, E., Rehal, A., Pazos, A., et al. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.08.110 · Cited by 169
Self-citationChaemsaithong, P., Pooh, R. K., Zheng, M., Ma, R., Chaiyasit, N., Tokunaka, M., Shaw, S. W., Seshadri, S., Choolani, M., Wataganara, T., et al. (2019) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2019.09.041 · Cited by 169
Self-citationSubtil, D., Goeusse, P., Houfflin‐Debarge, V., Puech, F., Lequien, P., Bréart, G., Uzan, S., Quandalle, F., Delcourt, Y. M., Malek, Y. M., et al. (2003) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1046/j.1471-0528.2003.t01-1-02097.x · Cited by 163
Konijnenberg, A., Stokkers, E. W., van der Post, J., Schaapb, M. C. L., Boer, K., Bleker, O. P., & Sturk, A. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70516-7 · Cited by 152
Hidden high rate of pre‐eclampsia in twin compared with singleton pregnancy
Francisco, C., Wright, D. E., Benkő, Z., Syngelaki, A., & Nicolaides, K. H. (2017) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.17470 · Cited by 152
Self-citationPrediction and prevention of small‐for‐gestational‐age neonates: evidence from SPREE and ASPRE
Tan, M. Y., Poon, L. C., Rolnik, D. L., Syngelaki, A., Matallana, C. D. P., Akolekar, R., Cicero, S., JANGA, D., Singh, M., Molina, F. S., et al. (2018) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.19077 · Cited by 146
Self-citationRoberge, S., Bujold, E., & Nicolaides, K. H. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.12.238 · Cited by 141
Self-citationWright, D. E., Rolnik, D. L., Syngelaki, A., Matallana, C. D. P., Machuca, M., de Alvarado, M., Mastrodima, S., Tan, M. Y., Shearing, S., Persico, N., et al. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.02.014 · Cited by 134
Self-citationSubtil, D., Goeusse, P., Puech, F., Lequien, P., Biausque, S., Bréart, G., Uzan, S., Marquis, P., Parmentier, D., Churlet, A., et al. (2003) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1046/j.1471-0528.2003.02096.x · Cited by 133
CLASP Collaborative Group CLASP Coordinating Centre, R. I. (1995) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1995.tb10872.x · Cited by 122
Aspirin for the Prevention of Preterm and Term Preeclampsia: Systematic Review and Meta-Analysis
Roberge, S., Bujold, E., & Nicolaides, K. H. (2018) · Obstetric Anesthesia Digest · doi:10.1097/01.aoa.0000547277.94540.23 · Cited by 120
Self-citationWerner, E. F., Hauspurg, A. K., & Rouse, D. J. (2015) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000001115 · Cited by 113
Nørgård, B. M., Horváth–Puhó, E., Czeizel, A. E., Skriver, M. V., & Sørensen, H. T. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.10.598 · Cited by 108
Aspirin delays the development of preeclampsia
Wright, D. E., & Nicolaides, K. H. (2019) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2019.02.034 · Cited by 91
Self-citationLi, C., Raikwar, N. S., Santillan, M. K., Santillan, D. A., & Thomas, C. P. (2015) · Placenta · doi:10.1016/j.placenta.2015.01.004 · Cited by 89
O’Gorman, N., Wright, D. E., Rolnik, D. L., Nicolaides, K. H., & Poon, L. C. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011801 · Cited by 89
Self-citationShould we recommend universal aspirin for all pregnant women?
Mone, F., Mulcahy, C., McParland, P., & McAuliffe, F. M. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.09.086 · Cited by 87
Strategies for Prescribing Aspirin to Prevent Preeclampsia: A Cost-Effectiveness Analysis
Mallampati, D. P., Grobman, W. A., Rouse, D. J., & Werner, E. F. (2019) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000003413 · Cited by 87
Economic assessment of screening for pre‐eclampsia
Shmueli, A., Meiri, H., & Gonen, R. (2012) · Prenatal Diagnosis · doi:10.1002/pd.2871 · Cited by 79
Mone, F., Mulcahy, C., McParland, P., Breathnach, F., Downey, P., McCormack, D., Culliton, M., Stanton, A. V., Cody, F., Morrison, J. J., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-022056 · Cited by 77
Tóth, L. F., Muszbek, L., & Komáromi, I. (2013) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2012.12.013 · Cited by 71
Use of paracetamol, ibuprofen or aspirin in pregnancy and risk of cerebral palsy in the child
Petersen, T. G., Liew, Z., Andersen, A. N., Andersen, G. L., Andersen, P. K., Martinussen, T., Olsen, J., Rebordosa, C., Tollånes, M. C., Uldall, P. V., et al. (2017) · International Journal of Epidemiology · doi:10.1093/ije/dyx235 · Cited by 70
Francisco, C., Wright, D., Benkő, Z., Syngelaki, A., & Nicolaides, K. H. (2017) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.17531 · Cited by 68
Self-citationOrtved, D., Hawkins, T. L., Johnson, J.-A., Hyett, J. A., & Metcalfe, A. (2018) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.19076 · Cited by 66
Cardiac function in fetuses and newborns exposed to low-dose aspirin during pregnancy
DiSessa, T. G., Moretti, M. L., Khoury, A., Pulliam, D. A., Arheart, K. L., & Sibai, B. M. (1994) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(94)70056-7 · Cited by 59
Mone, F., O’Mahony, J. F., Tyrrell, E., Mulcahy, C., McParland, P., Breathnach, F., Morrison, J. J., Higgins, J., Daly, S., Cotter, A. M., et al. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11718 · Cited by 56
Low dose aspirin and pregnancy: how important is aspirin resistance?
Navaratnam, K., Alfirevic, A., & Alfirević, Ž. (2016) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.13914 · Cited by 54
Su, M., Wang, C., Tsai, P., Chen, T.-Y., Tsai, H.-L., & Kuo, P. (2019) · Journal of Hypertension · doi:10.1097/hjh.0000000000002185 · Cited by 50
Francisco, C., Wright, D., Benkő, Z., Syngelaki, A., & Nicolaides, K. H. (2017) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.17529 · Cited by 47
Self-citationBreetveld, N. M., Ghossein‐Doha, C., van Neer, J., Sengers, M. J. J. M., Geerts, L., van Kuijk, S. M. J., van Dijk, A. P. J., van der Vlugt, M. J., Heidema, W. M., Rocca, H. B., et al. (2017) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.17534 · Cited by 40
The role of aspirin in prevention of preeclampsia in twin pregnancies: does the dose matter?
Kalafat, E., Shirazi, A., Thilaganathan, B., & Khalil, A. A. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.03.005 · Cited by 36
Management of pregnancies complicated by hypertensive disorders of pregnancy: Could we do better?
Helou, A., Walker, S. P., Stewart, K., & George, J. (2016) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.12499 · Cited by 33
Cunha, F. (1949) · The American Journal of Surgery · doi:10.1016/0002-9610(49)90394-3 · Cited by 30
Ling, H. Z., Jara, P. G., Bisquera, A., Poon, L. C., Nicolaides, K. H., & Kametas, N. A. (2020) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.16193 · Cited by 21
Self-citationLow Rates of Aspirin Use for the Prevention of Preeclampsia
Viguiliouk, E., Park, A. L., Berger, H. M., Geary, M. P., & Ray, J. G. (2017) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2017.04.040 · Cited by 20
Benkő, Z., Chaveeva, P., Matallana, C. D. P., Zingler, E., Wright, D. E., & Nicolaides, K. H. (2019) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.20411 · Cited by 19
Self-citation
Cited by
Magee, L. A., Brown, M. A., Hall, D. R., Gupte, S., Hennessy, A., Karumanchi, S. A., Kenny, L. C., McCarthy, F., Myers, J., Poon, L. C., et al. (2022) · Pregnancy Hypertension · doi:10.1016/j.preghy.2021.09.008 · Cited by 1,134
Self-citation2025 ESC Guidelines for the management of cardiovascular disease and pregnancy
De Backer, J., Haugaa, K. H., Hasselberg, N. E., de Hosson, M., Brida, M., Castelletti, S., Cauldwell, M., Cerbai, E., Crotti, L., de Groot, N. M. S., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf193 · Cited by 307
Guerby, P., Tasta, O., Swiader, A., Pont, F., Bujold, E., Parant, O., Vayssiere, C., Salvayre, R., & Negre-Salvayre, A. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101861 · Cited by 272
Chang, K.-J., Seow, K.-M., & Chen, K.-H. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20042994 · Cited by 266
The exciting potential for ChatGPT in obstetrics and gynecology
Grünebaum, A., Chervenak, J., Pollet, S. L., Katz, A., & Chervenak, F. A. (2023) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2023.03.009 · Cited by 234
Metadata
- Authors
- Rolnik, D. L., Nicolaides, K. H., & Poon, L. C.
- Venue
- American Journal of Obstetrics and Gynecology
- Publisher
- Elsevier BV
- Published
- 2022-02
- Volume
- 226
- Issue
- 2
- Pages
- S1108-S1119
- ISSN
- 0002-9378 (ISSN-L)
- OpenAlex
- W3081112584
- Cited by
- 390
- References
- 85
- FWCI
- 20.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.